Skip to main content

Sackler Family Aims Global Settlement For Opioid Lawsuits

Sackler Family Aims Global Settlement For Opioid Lawsuits

Sackler Family Aims Global Settlement For Opioid Lawsuits

Introduction

Purdue Pharma is facing more than 2,000 opioid lawsuits from different states, cities, and counties. Mary Jo White, attorney of Sackler family who owns Purdue Pharma, recently stated litigation against the family and their company was legally unreliable and factually misleading, but still, they are ready for the global opioid settlement.

Arkansas’s Attorney General Leslie Rutledge, filed a lawsuit in the Pulaski Circuit Court against three opioid distributors, AmerisourceBergen Drug Corporation, McKesson Corporation, and Cardinal Health. She stated these distributors control 85 percent of the national opioid market share and collectively make more than $375 billion in annual revenue. Rutledge also filed a lawsuit last year against Purdue Pharma, Johnson & Johnson and Endo Pharmaceuticals for misleading the public on the dangers of opioids. Camden Clark Memorial Hospital Corporation in West Virginia along with 27 others have sued opioid manufacturers, distributors and others on similar lawsuit. Fourteen other states and one U.S. territory are also currently pursuing lawsuits against opioid manufacturers and distributors.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!